Particle.news
Download on the App Store

Remedy’s New CEO Pushes IP Growth Through Film and TV Without Changing the DNA

Jean-Charles Gaudechon is refocusing the studio on turning Control and Alan Wake into bigger franchises via Annapurna-backed adaptations to reach wider audiences.

Overview

  • Remedy appointed Jean-Charles Gaudechon as CEO in February after FBC: Firebreak underperformance prompted a leadership change.
  • In late May Gaudechon said Alan Wake and Control “should have sold more” and recommended using the 2024 Annapurna deal to drive film and TV adaptations that raise awareness and sales.
  • He pledged to preserve Remedy’s creative identity, rejected chasing free-to-play mobile deals, and said he is cautious about using generative AI for core creative work.
  • Remedy confirmed Control Resonant remains on track for a 2026 release on consoles and PC and will focus on Dylan as its protagonist.
  • The studio is balancing the push to monetise existing IP with financial recovery after Firebreak’s weak sales led to a revised FY25 outlook and a €14.9 million non-cash impairment.